GRI-0803 — IND submission
in 2026
We intend to complete IND-enabling studies and file an IND application to evaluate GRI-0803 in a Phase 1a and 1b trial in healthy volunteers in 2026.Source filing
GRI biotech catalysts & pipeline
GRI BIO INC · Data as of 2026-09-08